Targeting heme oxygenase-1 in vascular disease

Current Drug Targets

Volumn 11, Issue 12, 2010, Pages 1504-1516

  Durante, William ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Atherosclerosis; Bilirubin; Biliverdin; Carbon monoxide; Heme oxygenase 1; Hypertension; Myocardial infarction; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE; CARBON MONOXIDE; ENZYME INHIBITOR; GLUTAMINE; HEME OXYGENASE 1; HEMIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIDAZOLE; METHIONINE; NITRATE; PACLITAXEL; PENTAESITHRITYL TETRANITRATE; PROBUCOL; RAPAMYCIN; RESVERATROL; SILDENAFIL; UNCLASSIFIED DRUG; ZINC DEUTEROPORPHRYIN 2,4 BIS GLYCOL;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR DISEASE; DRUG MECHANISM; ENZYME METABOLISM; ERECTILE DYSFUNCTION; GENE THERAPY; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERTENSION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VASCULAR DISEASE; ANIMAL; BIOSYNTHESIS; DRUG DESIGN; DRUG EFFECT; ENZYME INDUCTION; GENETICS; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; DRUG DESIGN; ENZYME INDUCTION; GENE THERAPY; HEME OXYGENASE-1; HUMANS; MOLECULAR TARGETED THERAPY; VASCULAR DISEASES;

EID: 79952276471     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450111009011504     Document Type: Article

References (185)

1. Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968; 61: 748-55.
2. Alam J, Cook JL. Transcriptional regulation of the heme oxygenase-1 gene via the stress response pathway. Curr Pharm Des 2003; 9: 2499-511.
3. Ferrandiz ML, Devesa I. Inducers of heme oxygenase-1. Curr Pharm Des 2008; 14:473-86.
4. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide from basic science to therapeutic implications. Physiol Rev 2006; 86: 583-650.
5. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008; 60: 79-127.
6. Durante W, Johnson FK, Johnson RA. Role of carbon monoxide in cardiovascular function. J Cell Mol Med 2006; 10: 672-86.
7. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997; 94: 10925-30.
8. Yet SF, Layne MD, Liu X, et al. Absence of heme oxygenase-1 exacerbates atherosclerosis lesion formation and vascular remodeling. FASEB J 2003; 17: 1759-61.
9. Yachie A, Niida Y, Wada T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999; 103: 129-35.
10. Kawashima A, Oda T, Yachie A, Koizumi S, Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol 2002; 33: 125-30.
11. True AL, Olive M, Boehm M, et al. Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res 2007; 101: 893-901.
12. Juan SH, Lee TS, Tseng KW, et al. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001; 104: 1519-25.
13. Exner M, Minar E, Wagner O, Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 2004; 37: 1097-104.
14. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994; 40: 18-23.
15. Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral artery disease. Arterioscler Thromb Vasc Biol 2008; 28: 166-72.
16. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000; 46: 1723-7.
17. Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 1988; 152: 711-20.
18. Cheng C, Noordeloos AM, Jeney V, et al. Heme oxygenase-1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 2009; 119: 3017-27.
19. Song J, Sumiyoshi S, Nakashima Y, et al. Overexpression of heme oxygenase-1 in coronary atherosclerosis of Japanese autopsies with diabetes mellitus: Hisayama study. Atherosclerosis 2009; 202: 573-81.
20. Ameriso SF, Villamil AR, Zedda C, et al. Heme oxygenase-1 is expressed in carotid atherosclerotic plaque infected by Helicobacter pylori and is more prevalent in asymptomatic patients. Stroke 2005; 36: 1896-900.
21. Chen YH, Lin SY, Lin MW, et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type II diabetic patients. Hum Genet 2002; 111: 1-8.
22. Kaneda H, Ohno M, Taguchi J, et al. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 2002; 22: 1680-5.
23. Endler G, Exner M, Schillinger M, et al. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemostasis 2004; 91: 155-61.
24. Ono K, Goto Y, Takagi S, et al. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis 2004; 173: 315-9.
25. Ishikawa K, Sugawara D, Goto J, et al. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 2001; 104: 1831-6.
26. Ishikawa K, Sugawara D, Wang XP, et al. Heme oxygenase-1 inhibits atherosclerosis lesion formation in ldl-receptor knockout mice. Circ Res 2001; 88: 506-12.
27. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ. Induction of heme oxygenase-1 inhibits monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 1997; 100: 1209-16.
28. Foresti R, Sarathchandra P, Clark JE. Green CJ, Motterlini R. Peroxynitrite induces heme oxygenase-1 in vascular endothelial cells: a link to apoptosis. Biochem J 1999; 339: 729-36.
29. Liu XM, Peyton KJ, Ensenat D, et al. Endoplasmic reticulum stress stimulates heme oxygenase-1 gene expression in vascular smooth muscle: role in cell survival. J Biol Chem 2005; 280: 872-7.
30. Durante W, Kroll MH, Christodoulides N, Peyton KJ, Schafer AI. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 1997; 80: 557-64.
31. Hill-Kapturczak N, Truong L, Thamilselvan V, Visner GA, Nick HS, Agarwal A. Smad7-dependent regulation of heme oxygenase-1 by transforming growth factor-β in human renal epithelial cells. J Biol Chem 2000; 275: 40904-9.
32. Durante W, Peyton KJ, Schafer AI. Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19: 2666-72.
33. Wei Y, Liu XM, Peyton KJ, et al. Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival. Am J Physiol Cell Physiol 2009; 297: C907-15.
34. Ishikawa K, Sugawara D, Goto J, et al. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 2001; 104: 1831-6.
35. Bouche D, Chauveau BD, Roussel JC, et al. Inhibition of graft arteriosclerosis development in rat aortas following heme oxygenase-1 gene transfer. Transpl Immunol 2002; 9: 235-8.
36. Du D, Chang S, Chen B, Zhou H, Chen ZK. Adenovirus-mediated heme oxygenase transfer inhibits graft arteriosclerosis in rat aortic transplants. Transpl Proc 2007; 39: 3446-8.
37. Tsui TY, Wu X, Lau CK, et al. Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer. Circulation 2003; 107: 2623-9.
38. Orozco LD, Kapturczak MH, Barajas B, et al. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res 2007; 100: 1703-11.
39. Lee TS, Shiao MS, Pan CC, Chau LY. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 1999; 99: 1222-9.
40. Ferris CD, Jaffrey SR, Sawa A, et al. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1999; 1: 152-7.
41. Nakayama M, Takahashi K, Komaru T, et al. Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2001; 21: 1373-7.
42. Piantadosi CA, Carraway MS, Suliman HB. Carbon monoxide, oxidative stress, and mitochondrial permeability pore transition. Free Radic Biol Med 2006; 15: 40:1332-9.
43. Taille C, El-Benna J, Lanone S, Boczkowski, Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem 2005; 280: 25350-60.
44. Turkseven AM, Mingone CJ, Gupte SA, Wolin MS, Abraham NG. Heme oxygenase-1 gene expression increases vascular relaxation and decreases inducible nitric oxide synthase in diabetic rats. Cell Mol Biol 2005; 51: 371-6.
45. Kawamura K, Ishikawa K, Wada Y, et al. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 2005; 25: 155-60.
46. Di Pascoli M, Rodella L, Sacerdoti D, Bolognesi M, Turkseven S, Abraham NG. Chronic CO levels have a beneficial effect on vascular relaxation seen in diabetes. Biochem Biophys Res Commun 2006; 340: 935-43.
47. Tricot O, Mallat Z, Heymes C, Belmin J, Leseche G, Tedgui A. Relation between endothelial cell apoptosis and blood direction in human atherosclerotic plaques. Circulation 2000; 101: 2450-3.
48. Morse D, Lin L, Choi AM, Ryter SW. Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease. Free Radic Biol Med 2009; 47: 1-12.
49. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibodyinduced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998; 4: 1392-6.
50. Brouard S, Otterbein LE, Anrather J, et al. Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015-29.
51. Liu XM, Chapman GB, Peyton KJ, Schafer AI, Durante W. Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovascular Res 2002; 55: 396-405.
52. Liu XM, Chapman GB, Peyton KJ, Schafer AI, Durante W. Antiapoptotic action of carbon monoxide in cultured vascular smooth muscle cells. Exp Biol Med (Maywood) 2003; 228: 572-5.
53. Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006; 12: 1075-80.
54. Soares MP, Seldon MP, Gregoire IP, et al. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial activation. J Immunol 2004; 172: 3553-63.
55. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has antiinflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6: 422-8.
56. Sowle P, Foresti R, Mann BE, Johnson TR, Green CJ, Motterlini R. Carbon monoxide releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 2005; 145: 800-10.
57. Song R, Ning W, Liu F, et al. Regulation of IL-1β-induced GMCSF production in human airway smooth muscle cells by carbon monoxide. Am J Physiol Lung Cell Mol Physiol 2002; 27: L50-6.
58. Sarady-Andrews JK, Liu F, Gallo D, et al. Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 2005; 289: L1131-7.
59. Vachharajan TJ, Work J, Issekutz AC, Granger DN. Heme oxygenase modulates selectin expression in different vascular beds. Am J Physiol Heart Circ Physiol 2000; 278: H1613-7.
60. Aizawa T, Ishizaka N, Taguchi J, Kimura S, Kurokawa K, Ohno M. Balloon injury does not induce heme oxygenase-1 gene expression, but administration of hemin inhibits neointimal formation in balloon injured rat carotid arteries. Biochem Biophys Res Commun 1999; 261: 302-7.
61. Togane Y, Toshisuki M, Suematsu M, Ishimura Y, Yamazaki J, Katayama S. Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury. Am J Physiol Heart Circ Physiol 2000; 278: H623-32.
62. Tulis DA, Durante W, Peyton KJ, Evans AJ, Schafer AI. Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis 2001; 155: 113-22.
63. Duckers HJ, Boehm M, True AL, et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001; 7: 693-8.
64. Tulis DA, Durante W, Liu X, Evan AJ, Peyton KJ, Schafer AI. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 2001; 104: 2710-5.
65. Juncos JP, Tracz MJ, Croatt AJ, et al. Genetic deficiency of heme oxygenase-1 impairs functionality and form of arteriovenous fistula in the mouse. Kidney Int 2008; 74: 47-51.
66. Exner M, Schillinger M, Minar E, et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 2001; 8: 433-40.
67. Schillinger M, Exner M, Minar E, et al. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol 2004; 43: 950-7.
68. Lin CC, Yang WC, Lin SJ, et al. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int 2006; 69:165-72.
69. Chen Y-H, Chau L-Y, Lin M-W, et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur Heart J 2004; 25: 39-47.
70. Tiroch K, Koch W, von Beckerath N, Kastrati A, Schomig A. Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting. Eur. Heart J 2007; 28: 968-73.
71. Peyton KJ, Reyna SV, Chapman GB, et al. Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 2002; 51: 441-6.
72. Otterbein LE, Zuckerbraun BS, Haga M, et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 9: 183-90.
73. Ollinger R, Bilban M, Erat A, et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 2005; 112: 1030-9.
74. Nakao A, Murase N, Ho C, Toyokawa H, Billiar TR, Kanno S. Biliverdin administration prevents the formation of intimal hyperplasia induced by vascular injury. Circulation 2005; 112: 587-91.
75. Rodriguez AI, Gangopadhyay A, Kelley EE, Pagano PJ, Zuckerbraun BS, Bauer PM. HO-1 and CO decrease platelet-derived growth factor-induced vascular smooth muscle cell migration via inhibition of Nox1. Arterioscler Thromb Vasc Biol 2010; 30: 98-104.
76. Deramaudt BM, Braunstein S, Remy P, Abraham NG. Gene transfer of human heme oxygenase-1 into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 1998; 68: 121-7.
77. Deshane J, Chen S, Caballero S, et al. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 2007; 204: 605-18.
78. Bussolati B, Ahmed A, Pemberton H, et al. Bifunctional role of VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocyte infiltration. Blood 2004: 103: 761-6.
79. Wu BJ, Kathir K, Witting PK, et al. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 2006; 203: 1117-27.
80. Lin H-H, Chen Y-H, Yet S-F, Chau L-Y. After vascular injury, heme oxygenase-1/carbon monoxide enhances re-endothelialization via promoting mobilization of circulating endothelial progenitor cells. J Thromb Haemost 2009; 7: 1401-8.
81. Wu BJ, Midwinter RG, Cossano C, et al. Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2009; 29:1537-42.
82. Tracz MJ, Juncos JP, Grande JP, et al. Induction of heme oxygenase-1 is a beneficial response in a murine model of venous thrombosis. Am J Pathol 2008; 173: 1882-90.
83. Chen B, Guo L, Fan C, et al. Carbon monoxide rescues heme oxygenase-1-deficient mice from arterial thrombosis in allogeneic aortic transplantation. Am J Pathol 2009; 175: 422-9.
84. Peng L, Mundada L, Stomel JM, et al. Induction of heme oxygenase-1 expression inhibits platelet-dependent thrombosis. Antioxid Redox Signal 2004; 6: 729-35.
85. Lindenblatt N, Bordel R, Schareck W, Menger MD, Vollmar B. Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo. Arterioscler Thromb Vasc Biol 2004; 24: 1-6.
86. Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 1997; 100: 589-96.
87. Fujita T, Toda K, Karimova A, et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 2001; 7: 598-604.
88. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 2000; 278: H643-51.
89. Hangaishi M, Ishizaka N, Aizawa T, et al. Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem Biophys Res Commun 2000; 279: 582-8.
90. Masini E, Vannacci A, Marzocca C, et al. Heme oxygenase-1 and the ischemia-reperfusion injury in the rat heart. Exp Biol Med 2003; 228: 546-9.
91. mox-1 constitutes an adaptive response to effect antioxidant cardioprotection: a study with transgenic mice heterozygous for targeted disruption of the heme oxygenase-1 gene. Circulation 2001; 103: 1695-701.
92. Yet S-F, Tiang R, Layne MD, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 2001; 89: 168-73.
93. Vulapalli RS, Chen Z, Chua BHL, Wang T, Liang C-S. Cardioselective overexpression of HO-1 prevents cardiac dysfunction and apoptosis. Am J Physiol Heart Circ Physiol 2002; 283: H688-94.
94. Yet S-F, Perrella MA, Layne MD, et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 1999; 103: R23-9.
95. Melo LG, Agrawal R, Zhang L, et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virusmediated delivery of heme oxygenase gene. Circulation 2002; 105: 602-7.
96. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol 2000; 278: H643-51.
97. Clark JE, Naughton P, Shurey S, et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003; 93: e2-8.
98. Guo Y, Stein AB, Wu WJ, et al. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 2004; 286: H1649-53.
99. Stein AB, Guo Y, Tan W, et al. Administration of CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 2005; 38: 127-34.
100. Fujimoto H, Ohno M, Ayabe S, et al. Carbon monoxide protects against cardiac ischemia-reperfusion injury in vivo via MAPK and Akt-eNOS pathways. Arterioscler Thromb Vasc Biol 2004; 24; 1-7.
101. Lavitrano M, Smolesnki RT, Musumeci A, et al. Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. FASEB J 2004; 18: 1093-5.
102. Akamatsu Y, Haga M, Tyagi S, et al. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemic reperfusion injury. FASEB J 2004; 18: 771-2.
103. Nakao A, Choi AM, Murase N. Protective effect of carbon monoxide in transplantation. J Cell Mol Med 2006; 10: 650-71.
104. Johnson RA, Lavesa M, Askari B, Abraham NG, Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 1996; 25: 166-9.
105. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 1989; 243: 388-90.
106. Levere RD, Martasek P, Escalante B, Schwartzman ML, Abraham NG. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest 1990; 17: 776-9.
107. Sabaawy HE, Zhang F, Nguyen X, et al. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension 2001; 38: 210-5.
108. Wang R, Shamloul R, Wang X, Meng Q, Wu L. Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 2006; 48: 685-92.
109. Furchgott RF, Jothianandan D. Endothelium-dependent and-independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide, and light. Blood Vessels 1991; 28: 52-61.
110. Wang R, Wu L, Wang Z. The direct effect of carbon monoxide on KCa channels in vascular smooth muscle cells. Pflugers Arch 1997; 434: 285-91.
111. Morita T, Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 1995; 96: 2676-82.
112. Thorup C, Jones CL, Gross SS, Moore LC, Goligorsky MS. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol Heart Circ Physiol 1999; 277: F882-9.
113. Johnson RA, Colombari E, Columbari DS, Lavesa M, Talman WT. Role of endogenous carbon monoxide in central regulation of arterial pressure. Hypertension 1997; 30: 962-7.
114. Rodriguez F, Kemp R, Balazy M, Nasjletti A. Effects of exogenous heme on renal function: role of heme oxygenase and cyclooxygenase. Hypertension 2003; 42: 680-4.
115. Vera T, Kelsen S, Yanes LL, Reckelhoff JF, Stec DE. HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1472-8.
116. Yang L, Quan S, Nasjletti A, Laniado-Schwartzman M, Abraham NG. Heme oxygenase-1 gene expression modulates angiotensin IIinduced increase in blood pressure. Hypertension 2004; 43: 1-6.
117. Vera T, Kelsen S, Stec DE. Kidney-specific induction of heme oxygenase-1 prevents angiotensin II hypertension. Hypertension 2008; 52: 660-5.
118. Wiesel P, Patel AP, Carvajal IM, et al. Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice. Circ Res 2001; 88: 1088-94.
119. -/-mice and the Gunn rat. Am J Physiol Heart Circ Physiol 2007; 293: H333-42.
120. Christou H, Morita T, Hsieh C-M, et al. Prevention of hypoxiainduced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 2000; 86: 1224-9.
121. Minamino T, Christou H, Hsieh CM, et al. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA 2001; 98: 8798-803.
122. Zuckerbraun BS, Chin BY, Wegiel B, et al. Carbon monoxide reverses established pulmonary hypertension. J Exp Med 2006; 203: 2109-19.
123. Shimzu K, Takahashi T, Iwasaki T, et al. Hemin treatment abrogates monocrotaline-induced pulmonary hypertension. Med Chem 2008; 4: 572-6.
124. Tsui TY, Lau CK, Ma J, et al. Adeno-associated virus-mediated heme oxygenase-1 gene transfer suppresses the progression of micronodular cirrhosis in rats. World J Gastroenterol 2006; 12: 2016-23.
125. Johnson FK, Durante W, Peyton KJ, Johnson RA. Heme oxygenase inhibitor restores arteriolar nitric oxide function in DAHL rats. Hypertension 2003; 41: 149-55.
126. Teran FJ, Johnson RA, Stevenson BK, et al. Heme oxygenasederived carbon monoxide promotes arteriolar endothelial dysfunction and contributes to salt-induced hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 2005; 288: R615-22.
127. Johnson FK, Johnson RA, Durante W, Jackson KE, Stevenson BK, Peyton KJ. Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction. Am J Physiol Regul Integr Comp Physiol 2006; 290: R601-8.
128. Imai T, Morita T, Shindo T, et al. Vascular smooth muscle celldirected overexpression of heme oxygenase-1 elevates blood pressure through attenuation of nitric oxide-induced vasodilation in mice. Cir Res 2001; 89: 55-62.
129. Johnson FK, Johnson RA. Carbon monoxide promotes endotheliumdependent constriction of isolated gracilis muscle arterioles. Am J Physiol Heart Circ Physiol 2003; 285: R536-41.
130. Ishikawa M, Kajimura M, Adachi T, et al. Carbon monoxide from heme oxygenase-2 is a tonic regulator against NO-dependent vasodilation in the adult rat cerebral microcirculation. Circ Res 2005; 97: e104-14.
131. Morimoto Y, Durante W, Lancaster DG, Klattenhoff J, Tittel FK. Real-time measurements of endogenous CO production from vascular cells using an ultrasensitive laser sensor. Am J Physiol Heart Circ Physiol 2001; 280: H483-8.
132. Rank JM, Straka JG, Weimer MK, Boissenmaier, Taddeini BL, Bloomer JR. Hematin therapy in late onset congenital erythropoietic porphyria. Br J Haematol 1990; 75: 617-8.
133. Ruutu T, Volin L, Tenhunen R. Haeme arginate as a treatment for myelodysplastic syndromes. Br J Haematol 1987; 65: 425-8.
134. Dellon ES, Szczepiorkowski ZM, Dzik WH, et al. Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation 2002; 73: 911-5.
135. Rund D, Rachmilewitz E. New trends in the treatment of betathalasemmia. Crit Rev Oncol Hematol 2000; 33: 105-18.
136. Bharucha AE, Kulkarni A, Choi KM, et al. First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans. Clin Pharmacol Ther doi 10:1038/clpt 2009.221.
137. Wagener FA, Eggert A, Boerman OC, et al. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 2001; 98: 1802-11.
138. Ogborne RM, Rushworth SA, Charalambos CA, O'Connell MA. Haem oxygenase-1: a target for dietary antioxidants. Biochem Soc Trans 2004; 32: 1003-5.
139. Scapagnini G, Foresti R, Calabrese V, Giuffrida Stella AM, Green CJ, Motterlini R. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol 2002; 61: 554-61.
140. Wu CC, Hsu MC, Hsieh CW, Lin JB, Lai PH, Wung BS. Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci 2006; 78: 2889-97.
141. Penumathsa SV, Maulik N. Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can J Physiol Pharmacol 2009; 87: 275-86.
142. Cheng PY, Lee YM, Shih NL, Chen YC, Yen MH. Heme oxygenase-1 contributes to the cytoprotection of alpha-lipoic acid via the activation of p44/42 mitogen-activated protein kinase in vascular smooth muscle cells. Free Radic Biol Med 2006; 40: 1313-22.
143. Erdmann K, Grosser N, Schroder H. L-methionine reduces oxidant stress in endothelial cells: role of heme oxygenase-1, ferritin, and nitric oxide. AAPS J 2005; 7: E195-200.
144. Grosser N, Oberle S, Berndt G, Erdmann K, Hemmerle A, Schroder H. Antioxidant action of L-alanine: heme oxygenase-1 and ferritin as possible mediators. Biochem Biophys Res Commun 2004; 314: 351-5.
145. Uehara K, Takahashi T, Fujii H, et al. The lower intestinal tractspecific induction of heme oxygenase-1 by glutamine protects against endotoxemic intestinal injury. Crit Care Med 2005; 33: 381-90.
146. Grosser N, Hemmerle A, Berndt G, et al. The antioxidant defense protein heme oxygenase-1 is a novel target for statins in endothelial cells. Free Radic Biol Med 2004; 37: 2061-71.
147. Lee TS, Chang CC, Zhu Y, Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 2004; 110: 1296-302.
148. Hsu M, Muchova L, Moriaka I, Wong JR, Schroder H, Stevenson DK. Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem Biophys Res Commun 2006; 343: 738-44.
149. Loboda A, Jazwa A, Jozkowicz, et al. Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells. Atherosclerosis 2006; 187: 26-30.
150. Grosser N, Abate A, Oberle S, et al. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun 2003; 308: 956-60.
151. Oberle S, Oberle S, Abate A, et al. Endothelial protection by pentaerithrityl trinitrate: bilirubin and carbon monoxide as possible mediators. Exp Biol Med (Maywood) 2003; 228: 529-34.
152. Wenzel P, Oelze M, Coldewey M, et al. Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates. Arterioscler Thromb Vasc Biol 2007; 27: 1729-35.
153. Vidavalur R, Penumathsa SV, Zhan L, Thirunavukkarasu M, Maulik N. Sildenafil induces angiogenic response in human coronary arteriolar endothelial cells through the expression of thioredoxin, hemeoxygenase and vascular endothelial growth factor. Vascu Pharmacol 2006; 45: 91-5.
154. Abdel Aziz MT, El-Asmer MF, Mostafa T, et al. Heme oxygenase vs nitric oxide synthase in signaling mediating sildenafil citrate action. J Sex Med 2006; 4: 1098-107.
155. Visner GA, Lu F, Zhou H, Liu J, Kazemfar K, Agarwal A. Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin. Circulation 2003; 107: 911-6.
156. Zhou H, Liu H, Porvasnik SL, et al. Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension. Lab Invest 2006; 86: 62-71.
157. Choi BM, Kim YM, Jeong YR, et al. Induction of heme oxygenase-1 is involved in the antiproliferative effects of paclitaxel in rat vascular smooth muscle cells. Biochem Biophys Res Commun 2004; 25: 39-47.
158. Schmidt R. Cobalt protoporphyrin as a potential therapeutic agent? FASEB J 2007; 21: 2639.
159. Liu XM, Chapman GB, Wang H, Durante W. Adenovirus-mediated heme oxygenase-1 gene expression stimulates apoptosis in vascular smooth muscle cells. Circulation 2002; 105: 79-84.
160. Suttner DM, Dennery PA. Reversal of HO-1 related cytoprotection with increased expression due to reactive iron. FASEB J 1999; 13: 1800-9.
161. Abraham NG, Asija A, Drummond G, Peterson S. Heme oxygenase-1 gene therapy: recent advances and therapeutic applications. Curr Gene Ther 2007; 7: 89-108.
162. Tang YL, Qian K, Zhang YC, Shen L, Phillips MI. A vigilant, hypoxia-regulatable heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo. J. Cardiovasc Pharmacol Ther 2005; 10: 251-63.
163. Moore BA, Overhaus M, Whitcomb J, et al. Brief inhalation of lowdose carbon monoxide prevents graft-induced intimal hyperplasia in swine. J Surg. Res 2007; 138: 121-7.
164. Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, Vercelotti GM. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle cell mice. J Clin Invest 2006; 116: 808-16.
165. Ott MC, Scott JR, Bihari A, et al. Inhalation of carbon monoxide prevents liver injury and inflammation following hindlimb ischemia/reperfusion. FASEB J 2005; 19: 106-8.
166. Mayr FB, Spiel A, Leitner J, et al. Effect of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med 2005; 171: 354-60.
167. Bathoorn E, Slebos D-J, Postma DS, et al. Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J 2007; 30: 1131-7.
168. Tulis DA, Keswani AN, Peyton KJ, Wang H, Schafer AI, Durante W. Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. Cell Mol Biol 2005; 51: 441-6.
169. Nakao A, Schmidt J, Harada T, et al. A single intraperitoneal dose of carbon monoxide-saturated Ringer's lactate solution ameliorates post-operative ileus in mice. J Pharmacol Exp Ther 2006; 319: 1265-75.
170. Chauveau C, Bouchet D, Roussel JC, et al. Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2002; 2: 581-92.
171. Rioux JP, Myers RA. Methylene chloride poisoning: a paradigmatic review. J Emerg Med 1988; 6: 227-38.
172. Foresti R, Shurey C, Ansari T, et al. Reviewing the use of carbon monoxide-releasing molecules (CO-RMs) in biology: implications in endotoxin-mediated vascular dysfunction. Cell Mol Biol (Noisyle-grand) 2005; 51: 409-23.
173. Friebe A, Schultz G, Koesling D. Sensitizing soluble guanylate cyclase to become a highly CO-sensitive enzyme. EMBO J 1996; 15: 6863-8.
174. McLaughlin BE, Chretien ML, Choi C, Brien JF, Nakatsu K, Marks GS. Potentiation of carbon monoxide-induced relaxation of rat aorta by YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole]. Can J Physiol Pharmacol 2000; 78: 343-9.
175. Liu XM, Peyton KJ, Mendelev NN, Wang H, Tulis DA, Durante W. YC-1 stimulates the expression of gaseous monoxides in vascular smooth muscle cells. Mol Pharmacol 2009; 75: 208-17.
176. Matsumoto N, Nakashima T, Kashima K. Effectiveness of bovine gallstone (Goou) and bear gall powder (Yutan) on chronic liver diseases: a preliminary report. Tokai J Exp Ther 1995; 20: 9-16.
177. Kapitulnik J. Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol 2004; 66: 773-9.
178. Nakao A, Neto JS, Kanno S, et al. Protection against ischemia/ reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 2005; 5: 282-91.
179. Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008; 198: 1-11.
180. Cary SP, Marletta MA. The case of CO signaling: why the jury is still out. J Clin Invest 2001; 107: 1071-3.
181. Grundemar L, Ny L. Pitfalls using metalloprophyrins in carbon monoxide research. Trends Pharmacol Sci 1997; 18: 193-5.
182. Kinobe RT, Dercho RA, Nakatsu K. Inhibitors of the heme oxygenase-carbon monoxide system: on the doorstep of the clinic? Can J Physiol Pharmacol 2008; 86: 577-99.
183. Quan S, Yang L, Abraham NG, Kappas A. Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs. Proc Natl Acad Sci USA 2001; 98: 12203-8.
184. Lin CC, Liu XM, Peyton KJ, et al. Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1. Arterioscler Thromb Vasc Biol 2008; 28: 739-45.
185. Zhang X, Shan P, Jiang D, et al. Small interference RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J Biol Chem 2003; 279: 10677-84.